STONERIDGE INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data STONERIDGE INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	696	824	866	834	648	770	900	976	908	861
Cost of revenue	501	576	610	621	494	604	725	775	719	690
Gross profit	195	248	257	214	154	167	175	201	189	171
Research and development	40.2	48.9	51.1	52.2	49.4	66.2	65.3	71.1	72.2	62.5
Selling, general and administrative	111	142	139	124	112	116	107	117	117	126
Operating income	44.1	57.4	67	71.3	-7.66	15.4	2.94	12.8	-0.38	-38.6
Interest expense						-5.19	-7.1	-13
Other non-operating income	0.15	-0.64	0.74	-0.14	1.53	-1.44	-5.71	-1.24	2.52	-3.61
Pre-tax income	39.2	52.6	65.1	68.4	-10.7	12.4	-10.7	-1.92	-13.6	-55.5
Income tax	-36.4	7.53	11.2	8.1	-2.77	9.03	3.36	3.26	2.93	47.4
Net income to minority interests	-1.89	-0.13
Net income	77.5	45.2	53.8	60.3	-7.95	3.41	-14.1	-5.18	-16.5	-103
EBITDA	67.3	85.3	96.2	102	25.1	49.2	36.6	46.5	33.9	-6.12
EPS, basic	2.79	1.61	1.90	2.17	-0.29	0.13	-0.52	-0.19	-0.60	-3.70
EPS, diluted	2.74	1.57	1.85	2.13	-0.29	0.12	-0.52	-0.19	-0.60	-3.70
Shares, basic (weighted)	27.8	28.1	28.4	27.8	27	27.1	27.3	27.4	27.6	27.8
Shares, diluted (weighted)	28.3	28.8	29.1	28.3	27	27.4	27.3	27.4	27.6	27.8

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	50.4	66	81.1	69.4	73.9	85.5	54.8	40.8	71.8	53.1
Receivables	113	142	139	139	137	150	158	167	138	89
Inventory	60.1	73.5	79.3	93.4	90.5	138	153	188	151	106
Other current assets	17.2	21.5	20.7	29.9	33.5	36.8	44	34.2	26.6	27
Total current assets	241	303	320	331	335	411	410	429	388	362
Property, plant and equipment	91.5	110	112	122	119	108	105	110	97.7	62.7
Lease right-of-use assets				22	18.9	18.3	13.8	10.8	10.1	9.57
Goodwill	0.93	38.4	36.7	35.9	39.1	36.4	34.2	35.3	33.1	37.6
Intangible assets	39.3	75.2	62	58.1	55.4	49.9	45.5	47.3	39.7	37.6
Total assets	395	559	560	602	621	665	652	680	622	551
Accounts payable	62.6	79.4	87.9	80.7	86.1	97.7	110	112	83.5	62.4
Accrued liabilities	16.3	22.4	18.7	19.6	21.9	18.7	19	23.9	21.2	25.8
Short-term debt	8.63	4.19	1.53	2.67	7.67	5.25	1.45	2.11	0
Total current liabilities	113	136	147	139	146	173	178	178	150	157
Long-term debt	8.06	3.85	0.98	0.45		0	0	0	0
Lease liabilities				18	15.4	14.9	10.6	7.68	6.48	6.6
Other non-current liabilities	4.92	35.1	17.1	16.8	14.4	6.81	6.58	9.69	12.9	11.6
Total liabilities	202	315	276	312	325	369	371	392	376	371
Total debt	83.7	129	98.5	129	144	169	169	191	202	181
Paid-in capital	207	228	232	226	234	232	233	227	226	219
Retained earnings	45.4	92.3	146	207	212	216	202	197	180	77.2
Treasury stock	-5.63	-7.12	-8.88	-50.8	-60.5	-55.3	-50.4	-43.3	-38.4	-27.5
Other comprehensive income	-67.9	-69.6	-85.8	-91.5	-89.6	-97	-103	-92.8	-122	-89.1
Shareholders' equity	178	244	283	290	297	296	281	288	245	180
Minority interests	13.8
Total equity	192	244	283	290	297	296	281	288	245	180
Total liabilities and equity	395	559	560	602	621	665	652	680	622	551
Shares outstanding	27.9	28.2	28.5	27.4	27	27.2	27.3	27.5	27.7	28

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	75.6	45	53.8	60.3	-7.95	3.41	-14.1	-5.18	-16.5	-103
Depreciation and amortization	23.3	27.9	29.2	30.9	32.7	33.8	33.7	33.6	34.3	32.5
Stock-based compensation	6.13	7.27	5.63	6.19	5.89	5.96	5.94	3.32	4.09	4.8
Deferred income tax	-38.7	-5.96	2.55	5.59	-7.95	-0.51	-5.11	-4.04	-5.74	37.1
Change in receivables	-18.7	-15.2	-3.58	-1.35	4.16	-17	-13.2	-5.85	20.2	17.3
Change in inventory	4.52	-2.13	-10	-15.7	4	-51.3	-20.1	-31.6	26.9	30.8
Cash from operations	65.3	78.9	80.8	24.5	28.6	-36.2	6.81	4.95	47.7	34
Capital expenditures	-24.5	-32.2	-29	-35.8	-27.7	-22.9	-27.2	-38.5	-24.3	-21.9
Acquisitions		-77.3
Cash from investing	-23.8	-109	-28	-6.3	-33.9	28	-28.6	-37	-24.5	-21.8
Share buybacks				-50	-5	0	0
Cash from financing	-43.4	40.8	-33.9	-28.3	6.51	22.9	-7.3	17.5	11.1	-25.3
Exchange rate effect	-2.05	4.56	-3.86	-1.64	3.25	-3.04	-1.68	0.59	-3.41	7.52
Net change in cash	-3.97	15.6	15.1	-11.7	4.52	11.6	-30.7	-14	31	-5.58
Free cash flow	40.8	46.7	51.7	-11.3	0.98	-59.2	-20.4	-33.6	23.4	12.2
Interest paid	5.79	5.75	5	4.4	5.62	6.06	7.29	13	15.5	14.2
Income taxes paid	3.39	7.09	13.2	12.2	-0.25	11.3	6.18	10.3	9.26	10.3

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $6.93 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	32.0%	Gross profit / revenue.
Operating margin	-4.5%	Operating income / revenue.
EBITDA margin	-1.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-6.3%	Pre-tax income / revenue.
Net margin	-13.3%	Net income / revenue.
FCF margin	-0.5%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	1.5%	Cash from operations / revenue.
Return on equity (ROE)	-80.1%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-23.6%	Net income / average total assets.
Return on invested capital (ROIC)	-41.0%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	5.5%	Research and development expense / revenue.
SG&A / revenue	13.3%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.8%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.0%	Capital expenditures / revenue.
D&A / revenue	3.2%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-5.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-1.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	5.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-9.6%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-0.7%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	2.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-118.1%	EBITDA vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-28.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	71.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	3.5%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-48.1%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	65.5%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-26.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-13.8%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-9.5%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-11.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-5.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-2.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.7%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.7%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.6%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.89x	Current assets / current liabilities.
Quick ratio	1.14x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.39x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	70.6%	Total liabilities / total assets.
Working capital	$162.2M	Current assets - current liabilities.
Goodwill and intangibles / assets	13.7%	(Goodwill + intangible assets) / total assets.
Tangible book value	$79.5M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.77x	Revenue / average total assets.
Fixed asset turnover	14.7x	Revenue / average property, plant and equipment.
Inventory turnover	5.40x	Cost of revenue / average inventory.
Days inventory	68 days	365 x average inventory / cost of revenue.
Receivables turnover	6.61x	Revenue / average receivables.
Days sales outstanding	55 days	365 x average receivables / revenue.
Days payables	65 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	58 days	Days inventory + days sales outstanding - days payables.
Capex / operating cash flow	135.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$4.23	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$31.76	Revenue / diluted weighted shares.
FCF per share	-$0.16	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.47	Cash from operations / diluted weighted shares.
Book value per share	$5.23	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$2.79	Tangible book value / shares outstanding.
Cash per share	$2.51	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$197.7M	Share price x shares outstanding.
Enterprise value	$126.1M	Market cap + total debt - cash - short-term investments.
P/S	0.22x	Market cap / revenue.
P/B	1.33x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	2.49x	Market cap / tangible book value, when positive.
P/OCF	14.9x	Market cap / cash from operations, when positive.
EV/Sales	0.14x	Enterprise value / revenue.
FCF yield	-2.4%	Free cash flow / market cap.
Earnings yield	-60.4%	Net income / market cap (the inverse of P/E).

What was STONERIDGE INC's revenue in fiscal 2025?

STONERIDGE INC reported revenue of $861.3M for fiscal 2025, 5.2% lower than the year before.

Was STONERIDGE INC profitable in fiscal 2025?

No. It reported a net loss of $102.8M.

How much free cash flow did STONERIDGE INC generate in fiscal 2025?

Cash from operations of $34.0M minus capital expenditures of $21.9M left free cash flow of $12.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to STONERIDGE INC